BlackRock Institutional Trust’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$347K Sell
25,828
-31
-0.1% -$461 ﹤0.01% 3514
2016
Q3
$413K Hold
25,859
﹤0.01% 3524
2016
Q2
$403K Sell
25,859
-22,436
-46% -$395K ﹤0.01% 3544
2016
Q1
$916K Sell
48,295
-266
-0.5% -$4.27K ﹤0.01% 3304
2015
Q4
$1.08M Buy
48,561
+466
+1% +$11K ﹤0.01% 3303
2015
Q3
$1.03M Buy
48,095
+14,050
+41% +$1.11M ﹤0.01% 3332
2015
Q2
$3.08M Sell
34,045
-4,408
-11% -$466K ﹤0.01% 2947
2015
Q1
$4.69M Buy
38,453
+21,067
+121% +$2.21M ﹤0.01% 2780
2014
Q4
$1.91M Sell
17,386
-349
-2% -$37.7K ﹤0.01% 3127
2014
Q3
$1.81M Buy
17,735
+138
+0.8% +$14.5K ﹤0.01% 3120
2014
Q2
$1.91M Buy
17,597
+2,850
+19% +$310K ﹤0.01% 3210
2014
Q1
$1.91M Sell
14,747
-908
-6% -$145K ﹤0.01% 3184
2013
Q4
$2.14M Sell
15,655
-2,237
-13% -$294K ﹤0.01% 3130
2013
Q3
$2.67M Buy
17,892
+2,648
+17% +$462K ﹤0.01% 2993
2013
Q2
$2.54M Buy
+15,244
New +$1.84M ﹤0.01% 2979

Other funds holding VSTM

BlackRock Institutional Trust's VSTM Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Verastem (VSTM) stake by 0.12% in Q4 2016, selling an estimated $461 and leaving 25,828 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #3514.

BlackRock Institutional Trust first reported a position in VSTM in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.69M in Q1 2015. 56 funds tracked by Wall St. Rank hold VSTM as of Q4 2016.

  • BlackRock Institutional Trust held 25,828 shares of Verastem worth $347K as of Q4 2016.
  • BlackRock Institutional Trust sold 31 Verastem shares in Q4 2016, an estimated $461.
  • Verastem made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3514 holding.
  • BlackRock Institutional Trust first reported a position in Verastem in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Verastem position peaked at $4.69M in Q1 2015.
  • 56 funds tracked by Wall St. Rank held Verastem as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.